
TOKYO -- South Korean drugmaker Celltrion has recorded positive preclinical results for its coronavirus treatment, the company announced on Monday.
South Korean pharmaceutical records 100-fold viral load reduction
TOKYO -- South Korean drugmaker Celltrion has recorded positive preclinical results for its coronavirus treatment, the company announced on Monday.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.